Joshua Hunter S.

Joshua Hunter S. is an experienced sales professional with a diverse background in pharmaceutical sales and expertise in rare diseases and specialty pharmaceuticals. Currently serving as a Virtual Rare Disease Account Manager at EVERSANA since September 2024, Joshua supports UCB Pharmaceuticals in the sales of Rystiggo and Zilbrysq for Myasthenia Gravis patients. Prior roles include Specialty Pharmaceutical Sales Representative at IQVIA, where Joshua sold AIMOVIG for migraine prevention, and a Migraine Virtual Sales Manager at EVERSANA, overseeing a team that successfully launched Nurtec. Joshua has consistently demonstrated top performance across various positions, including notable achievements in COPD and influenza sales, and has a solid educational background with a Bachelor's Degree in Pre-Veterinary from Penn State University.